Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHA:605266)

SHA:605266 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	833.4	776.05	857.93	932.6	983.1	1,622
Trading Asset Securities	-	50	50	3	-	-
Cash & Short-Term Investments	833.4	826.05	907.93	935.6	983.1	1,622
Cash Growth	4.67%	-9.02%	-2.96%	-4.83%	-39.38%	265.82%
Accounts Receivable	569.66	425.75	440.48	591.65	227.87	166.7
Other Receivables	65.33	60.68	56.94	53.54	56.96	32.73
Receivables	634.99	486.44	497.42	645.19	284.83	199.43
Inventory	2,529	3,128	2,374	2,166	1,121	731.43
Prepaid Expenses	8.74	14.04	12.87	-	-	-
Other Current Assets	197.25	228.09	145.79	192.89	107.8	240.93
Total Current Assets	4,203	4,683	3,938	3,939	2,497	2,793
Property, Plant & Equipment	2,416	2,597	2,687	2,644	1,901	376.87
Long-Term Investments	26.97	30.54	47.42	18.34	9.8	-
Goodwill	2,456	2,456	2,403	2,243	415.3	57.58
Other Intangible Assets	83.96	85.36	92.2	90.46	44.75	33.52
Long-Term Deferred Tax Assets	262.73	280.17	285.43	287.22	14.64	5.96
Long-Term Deferred Charges	423.35	485.3	485.93	415.89	331.86	201.18
Other Long-Term Assets	9.13	6.05	10.61	6.18	-	-
Total Assets	9,881	10,623	9,949	9,644	5,214	3,469
Accounts Payable	2,123	2,783	2,639	2,756	1,695	1,426
Accrued Expenses	170.4	184.59	216.07	281.91	105.3	111.36
Short-Term Debt	2,069	1,604	749.61	201.48	30	74.08
Current Portion of Long-Term Debt	268.73	249.74	572.5	155.19	5.41	-
Current Portion of Leases	347.65	389.42	423.84	422.6	378.41	-
Current Income Taxes Payable	11.22	19.77	44.93	66.87	42.42	23.9
Current Unearned Revenue	35.03	25.23	28.49	37.43	18.07	12.44
Other Current Liabilities	125.92	212.14	185.57	304.14	146.67	70.85
Total Current Liabilities	5,151	5,467	4,860	4,225	2,421	1,719
Long-Term Debt	1,103	1,190	1,022	1,192	25.23	30.64
Long-Term Leases	785.28	909.27	927.52	963.28	842.93	-
Long-Term Unearned Revenue	11.3	11.53	11.96	12.63	13.06	8.51
Long-Term Deferred Tax Liabilities	234.7	265.03	282.25	275.44	19.03	8.9
Other Long-Term Liabilities	-	-	-	407.82	-	-
Total Liabilities	7,285	7,843	7,104	7,076	3,321	1,767
Common Stock	154.54	156.66	128.85	99.16	69.53	53
Additional Paid-In Capital	1,338	1,397	1,361	1,391	1,009	985.9
Retained Earnings	1,250	1,341	1,379	1,109	856.89	678.26
Treasury Stock	-145.44	-97.81	-7.15	-14.78	-25.75	-
Comprehensive Income & Other	-0.04	0.12	-	-	-	-
Total Common Equity	2,598	2,797	2,861	2,585	1,910	1,717
Minority Interest	-1.22	-16.68	-16.51	-16.59	-16.72	-15.45
Shareholders' Equity	2,597	2,781	2,845	2,568	1,893	1,702
Total Liabilities & Equity	9,881	10,623	9,949	9,644	5,214	3,469
Total Debt	4,573	4,342	3,696	2,935	1,282	104.72
Net Cash (Debt)	-3,740	-3,516	-2,788	-1,999	-298.88	1,517
Net Cash Growth	-	-	-	-	-	297.22%
Net Cash Per Share	-24.18	-22.78	-18.03	-13.17	-2.14	13.19
Filing Date Shares Outstanding	148.16	154.49	154.62	154.69	141	139.73
Total Common Shares Outstanding	148.16	154.49	154.62	154.69	141	139.73
Working Capital	-947.59	-784.78	-922.54	-285.78	76	1,075
Book Value Per Share	17.53	18.11	18.50	16.71	13.54	12.29
Tangible Book Value	57.52	255.83	365.8	251.51	1,450	1,626
Tangible Book Value Per Share	0.39	1.66	2.37	1.63	10.28	11.64
Buildings	963.43	906.25	902.64	891.8	369.39	358.62
Machinery	333.8	312.13	277.99	225.09	158.25	119.01
Construction In Progress	200.51	253.85	202.01	180.56	73.91	3.23

Source: S&P Global Market Intelligence. Standard template. Financial Sources.